189 related articles for article (PubMed ID: 32560527)
1. Recombinant Lactaptin Induces Immunogenic Cell Death and Creates an Antitumor Vaccination Effect in Vivo with Enhancement by an IDO Inhibitor.
Troitskaya O; Varlamov M; Nushtaeva A; Richter V; Koval O
Molecules; 2020 Jun; 25(12):. PubMed ID: 32560527
[TBL] [Abstract][Full Text] [Related]
2. A novel pro-apoptotic effector lactaptin inhibits tumor growth in mice models.
Koval OA; Fomin AS; Kaledin VI; Semenov DV; Potapenko MO; Kuligina EV; Nikolin VP; Nikitenko EV; Richter VA
Biochimie; 2012 Dec; 94(12):2467-74. PubMed ID: 22968174
[TBL] [Abstract][Full Text] [Related]
3. Lactaptin induces p53-independent cell death associated with features of apoptosis and autophagy and delays growth of breast cancer cells in mouse xenografts.
Koval OA; Tkachenko AV; Fomin AS; Semenov DV; Nushtaeva AA; Kuligina EV; Zavjalov EL; Richter VA
PLoS One; 2014; 9(4):e93921. PubMed ID: 24710119
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors.
Bagamanshina AV; Troitskaya OS; Nushtaeva AA; Yunusova AY; Starykovych MO; Kuligina EV; Kit YY; Richter M; Wohlfromm F; Kähne T; Lavrik IN; Richter VA; Koval OA
Biomed Res Int; 2019; 2019():4087160. PubMed ID: 31317028
[TBL] [Abstract][Full Text] [Related]
5. 4-Bromophenylhydrazinyl benzenesulfonylphenylureas as indoleamine 2,3-dioxygenase inhibitors with in vivo target inhibition and anti-tumor efficacy.
Lin SY; Yeh TK; Song JS; Hung MS; Cheng MF; Liao FY; Li AS; Cheng SY; Lin LM; Chiu CH; Wu MH; Lin YJ; Hsiao W; Sun M; Wang YH; Huang CH; Tang YC; Chang HH; Huang ZT; Chao YS; Shih C; Pan SL; Wu SY; Kuo CC; Ueng SH
Bioorg Chem; 2018 Apr; 77():600-607. PubMed ID: 29494816
[TBL] [Abstract][Full Text] [Related]
6. Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin.
Nemudraya AA; Kuligina EV; Ilyichev AA; Fomin AS; Stepanov GA; Savelyeva AV; Koval OA; Richter VA
Oncol Lett; 2016 Dec; 12(6):4547-4555. PubMed ID: 28105163
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin.
Nemudraya AA; Makartsova AA; Fomin AS; Nushtaeva AA; Koval OA; Richter VA; Kuligina EV
PLoS One; 2016; 11(8):e0160980. PubMed ID: 27513518
[TBL] [Abstract][Full Text] [Related]
9. Structural and Aggregation Features of a Human κ-Casein Fragment with Antitumor and Cell-Penetrating Properties.
Chinak OA; Shernyukov AV; Ovcherenko SS; Sviridov EA; Golyshev VM; Fomin AS; Pyshnaya IA; Kuligina EV; Richter VA; Bagryanskaya EG
Molecules; 2019 Aug; 24(16):. PubMed ID: 31408975
[TBL] [Abstract][Full Text] [Related]
10. [Immunogenicity of recombinant analog of antitumor protein lactaptin].
Tkachenko AV; Troitskaya OS; Semenov DV; Dmitrienko EV; Kuligina EV; Richter VA; Koval OA
Mol Biol (Mosk); 2017; 51(5):787-796. PubMed ID: 29116065
[TBL] [Abstract][Full Text] [Related]
11. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
[TBL] [Abstract][Full Text] [Related]
12. The anticancer peptide RT53 induces immunogenic cell death.
Pasquereau-Kotula E; Habault J; Kroemer G; Poyet JL
PLoS One; 2018; 13(8):e0201220. PubMed ID: 30080874
[TBL] [Abstract][Full Text] [Related]
13. Accelerated rejection of the second transplants of immunogenic tumor in mice under inhibition of indoleamine 2,3-dioxygenase activity by ethyl pyruvate.
Vasilyeva ED; Kaledin V; Nikolin VP; Popova NA; Kirilyuk IA; Grigor'ev IA
Exp Oncol; 2012; 34(1):66-8. PubMed ID: 22453153
[TBL] [Abstract][Full Text] [Related]
14. Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors.
Dolušić E; Larrieu P; Blanc S; Sapunaric F; Pouyez J; Moineaux L; Colette D; Stroobant V; Pilotte L; Colau D; Ferain T; Fraser G; Galleni M; Frère JM; Masereel B; Van den Eynde B; Wouters J; Frédérick R
Eur J Med Chem; 2011 Jul; 46(7):3058-65. PubMed ID: 21419531
[TBL] [Abstract][Full Text] [Related]
15. Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents.
Wen H; Liu Y; Wang S; Wang T; Zhang G; Chen X; Li Y; Cui H; Lai F; Sheng L
Molecules; 2019 Jun; 24(11):. PubMed ID: 31195673
[TBL] [Abstract][Full Text] [Related]
16. A combination of the metabolic enzyme inhibitor APO866 and the immune adjuvant L-1-methyl tryptophan induces additive antitumor activity.
Yang HJ; Yen MC; Lin CC; Lin CM; Chen YL; Weng TY; Huang TT; Wu CL; Lai MD
Exp Biol Med (Maywood); 2010 Jul; 235(7):869-76. PubMed ID: 20558841
[TBL] [Abstract][Full Text] [Related]
17. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
[TBL] [Abstract][Full Text] [Related]
18. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
19. Nanoscale Reduced Graphene Oxide-Mediated Photothermal Therapy Together with IDO Inhibition and PD-L1 Blockade Synergistically Promote Antitumor Immunity.
Yan M; Liu Y; Zhu X; Wang X; Liu L; Sun H; Wang C; Kong D; Ma G
ACS Appl Mater Interfaces; 2019 Jan; 11(2):1876-1885. PubMed ID: 30582788
[TBL] [Abstract][Full Text] [Related]
20. Recombinant analogs of a novel milk pro-apoptotic peptide, lactaptin, and their effect on cultured human cells.
Semenov DV; Fomin AS; Kuligina EV; Koval OA; Matveeva VA; Babkina IN; Tikunova NV; Richter VA
Protein J; 2010 Apr; 29(3):174-80. PubMed ID: 20232123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
